Prescription drug · NDA
Relenza (Zanamivir) NDC 50090-8016
Zanamivir 5 mg/1 · Powder · Respiratory (Inhalation) · A-S Medication Solutions
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 50090-8016-0 | 50090801600 | 5 PACKAGE in 1 CARTON (50090-8016-0) / 4 POWDER in 1 PACKAGEMarketed from Jul 16, 2026 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Relenza
- Generic name (nonproprietary)
- zanamivir
- Active ingredients
- Zanamivir — 5 mg/1
- Dosage form
- Powder
- Route
- Respiratory (Inhalation)
- Labeler
- A-S Medication SolutionsNDC labeler code 50090
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 021036
- Marketing start
- Listing expires
- Other FDA classes
- Neuraminidase Inhibitors (Mechanism)
- Identifiers
- Product ID 50090-8016_571ce280-f506-436c-b378-d570cceae236SPL ID 571ce280-f506-436c-b378-d570cceae236SPL set ID b4e68930-4e6d-4d27-b1f0-abf60d12e28dRxCUI 759471, 759473UNII L6O3XI777I
- Pharmacologic class
- Neuraminidase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N450090801600followed by a unit qualifier and the quantityPackage 50090-8016-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
RELENZA, an influenza virus neuraminidase inhibitor (NAI), is indicated for: Treatment of acute, uncomplicated influenza type A and B infections in patients aged 7 years and older who have been symptomatic for no more than 2 days. ( 1.1 ) Prophylaxis of influenza in patients aged 5 years and older. ( 1.2 ) Important Limitations of Use: Not recommended for treatment or prophylaxis of influenza in: • Individuals with underlying airways disease. ( 5.1 ) Not proven effective for: • Treatment in individuals with underlying airways disease. ( 1.3 ) • Prophylaxis in nursing home residents. ( 1.3 ) Not a substitute for annual influenza vaccination. ( 1.3 ) Consider available information on influenza…
Excerpt only. Read the full label for complete information.
About NDC 50090-8016
- What is NDC 50090-8016?
- 50090-8016 is the product NDC for Relenza (zanamivir), Zanamivir 5 mg/1 powder, listed with the FDA by A-S Medication Solutions. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Relenza (Zanamivir).
- What is the active ingredient?
- Zanamivir.
- Who is the labeler?
- A-S Medication Solutions, NDC labeler code 50090. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Relenza?
- 1 other product NDC are listed under this name. See all Relenza NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Relenza products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Relenzazanamivir | Zanamivir 5 mg/1 | PowderRespiratory (Inhalation) | GlaxoSmithKline LLC | 0173-0681 | 00173-0681-0100173-0681-22 |
Other NDCs under NDA 021036
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Relenzazanamivir | Zanamivir 5 mg/1 | PowderRespiratory (Inhalation) | GlaxoSmithKline LLC | 0173-0681 |